1. Home
  2. HOWL vs ACCL Comparison

HOWL vs ACCL Comparison

Compare HOWL & ACCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • ACCL
  • Stock Information
  • Founded
  • HOWL 2017
  • ACCL 2009
  • Country
  • HOWL United States
  • ACCL Hong Kong
  • Employees
  • HOWL N/A
  • ACCL N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • ACCL Professional Services
  • Sector
  • HOWL Health Care
  • ACCL Consumer Discretionary
  • Exchange
  • HOWL Nasdaq
  • ACCL Nasdaq
  • Market Cap
  • HOWL 64.5M
  • ACCL 57.8M
  • IPO Year
  • HOWL 2021
  • ACCL 2025
  • Fundamental
  • Price
  • HOWL $0.99
  • ACCL $3.87
  • Analyst Decision
  • HOWL Strong Buy
  • ACCL
  • Analyst Count
  • HOWL 5
  • ACCL 0
  • Target Price
  • HOWL $7.00
  • ACCL N/A
  • AVG Volume (30 Days)
  • HOWL 670.5K
  • ACCL 114.8K
  • Earning Date
  • HOWL 11-04-2025
  • ACCL 12-09-2025
  • Dividend Yield
  • HOWL N/A
  • ACCL N/A
  • EPS Growth
  • HOWL N/A
  • ACCL 2.91
  • EPS
  • HOWL N/A
  • ACCL 0.08
  • Revenue
  • HOWL N/A
  • ACCL $4,888,824.00
  • Revenue This Year
  • HOWL N/A
  • ACCL N/A
  • Revenue Next Year
  • HOWL N/A
  • ACCL N/A
  • P/E Ratio
  • HOWL N/A
  • ACCL $55.18
  • Revenue Growth
  • HOWL N/A
  • ACCL 11.91
  • 52 Week Low
  • HOWL $0.60
  • ACCL $2.10
  • 52 Week High
  • HOWL $2.38
  • ACCL $5.00
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 37.92
  • ACCL N/A
  • Support Level
  • HOWL $0.80
  • ACCL N/A
  • Resistance Level
  • HOWL $1.03
  • ACCL N/A
  • Average True Range (ATR)
  • HOWL 0.10
  • ACCL 0.00
  • MACD
  • HOWL 0.01
  • ACCL 0.00
  • Stochastic Oscillator
  • HOWL 43.93
  • ACCL 0.00

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About ACCL Acco Group Holdings Limited Ordinary Shares

Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.

Share on Social Networks: